India’s first indigenous COVID-19 vaccine has been approved by the Indian Drug Controller General (DCGI) for human trials. Development of the vaccine named ‘Covaxin’ has been done by Bharat Biotech in association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
The first and second phases of testing of the vaccine will begin in the country next month. The company said in a statement that the cooperation of the ICMR and NIV was important in the development of the vaccine.
30 groups are engaged in the work of Coronavirus Vaccine
Drug manufacturers around the world are engaged in an effort to develop a vaccine that can fight coronavirus. A leading manufacturer of vaccines and generic drugs, India hopes to play an important role in this race, with many institutions working with various drugs.
Unlock-2 starts on 1 July
Let us tell you that the coronavirus in India is going to wreak havoc, although the government has issued guidelines for the second phase of unlocking it. In Unlock-2 the new guidelines allow for more activities to be re-open outside the containment zones.
The new guidelines will be effective from 1 July 2020 and the process of opening the economy in a phased manner has been carried forward. The new guidelines are issued based on feedback received from state and union territories and extensive consultations with the respective central ministries and departments.